M&A - Target Group Inc.

Form Type: 10-K

Filing Date: 2025-03-27

Corporate Action: Acquisition

Type: Update

Accession Number: 000141057825000510

Filing Summary: This document covers Target Group Inc.'s annual report for the year ended December 31, 2024. The Company has significantly engaged in the cultivation, processing, and distribution of cannabis products. Target Group formed due to the legalization of cannabis in Canada and is strategically positioned for continuous growth in this sector. Notable acquisitions include Visava Inc., which owns Canary Rx Inc., facilitating production capabilities and potential revenue growth from cannabis. As of March 27, 2025, Target Group had 617,025,999 shares of Common Stock outstanding. The report also discusses the Company’s financial condition, risk factors, and internal controls, while emphasizing forward-looking statements concerning potential future growth and operational strategy. The cannabis market in Canada presents considerable opportunities with projections for annual revenue growth within the sector, aligning with the Company's emphasis on innovation and product development.

Document Link: View Document